Bougie O, and Weberpals JI. Clinical considerations of BRCA1- and BRCA2-mutation carriers: a review. (2011). International Journal of Surgery. Elsevier. 2011:374012. (PMID 22312502).
Burstein, H.J., Harris, J.R. and Morrow,M.. Malignant tumors of the breast. DeVita, V. T., Jr., Hellman, S., & Rosenberg, S. A., (Eds.). (2011). Cancer: Principles & Practice of Oncology. (9th Edition). Philadelphia: Lippincott Williams & Wilkins. 6:pp. 1401 - 1446.
Chen S and Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. (2007, April 10). Journal of Clinical Oncology. American Society of Clinical Oncology. 25(11): pp: 1329-33. (PMID 17416853).
Horsman D, Wilson BJ, Avard D, et al. Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation. (2007, January). Journal of Obstetrics and Gynaecology Canada (JOGC). The Society of Obstetricians and Gynaecologists of Canada (SOGC). 29(1): pp: 45-60. (PMID: 17346477).
Loud JT and Hutton SP. Genetic risk and hereditary cancer syndromes. Yarbro, CH, Wujcki D, & Holmes Gobel B. (eds.). (2011). Cancer Nursing: Principles and Practice. (7th Edition). Sudbury, MA: Jones and Bartlett. Chapter 7: pp: 135-163.
Mills, G. B., and Trahan Rieger, P. Genetic predisposition to cancer. Pollock, R. E., Doroshow, J. H. & Khayat, D. et al. (Eds.). (2004). UICC Manual of Clinical Oncology. (8th Edition). New Jersey: John Wiley & Sons, Inc. 4: pp.63-89.
Narod SA and Salmena L. BRCA1 and BRCA2 mutations and breast cancer. (2011, November). Discovery Medicine. Discovery Medicine. 12(66): pp: 445-53 (PMID: 22127115).
National Cancer Institute. (2012, July 13). Genetics of Breast and Ovarian Cancer (PDQ®) Health Professional Version. Bethesda, MD: National Cancer Institute.
National Cancer Institute. (2009, May 29). FactSheet: BRCA1 and BRCA2: Cancer Risk and Genetic Testing. Bethesda, MD: National Cancer Institute.
Pluta RM and Golub RM. BRCA genes and breast cancer. (2011, June 1). JAMA: Journal of the American Medical Association. Chicago: American Medical Association. 305(21): pp: 2244. (PMID: 21632489).
Pruthi S, Gostout BS, and Lindor NM. Identification and management of women With BRCA mutations or hereditary predisposition for breast and ovarian cancer. (2010, December). Mayo Clinic Proceedings. Mayo Foundation for Medical Education and Research. 85(12): pp: 1111-20 (PMID: 21123638).
Risch NJ and Whittemore AS. Genetic concepts and methods in epidemiologic research. Schottenfeld, D. & Fraumeni, J. F. Jr. (eds.). (2006). Cancer Epidemiology and Prevention. (3rd Edition). New York: Oxford University Press. Chapter 7: pp: 89-98.
Robson ME, Storm CD, Weitzel J, et al. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. (2010, February 10). Journal of Clinical Oncology. American Society of Clinical Oncology. 28(5): pp: 893-901 (PMID: 20065170).
Sifri R, Gangaharappa S, and Acheson LS. Identifying and testing for hereditary susceptibility to common cancers. (2004, November/December). CA: A Cancer Journal for Clinicians. Atlanta: American Cancer Society. 54(6): pp. 309-326 (PMID: 15537575).